S-1/A: Abacus Life Eyes $100 Million in Common Stock Offering to Fuel Growth

Abacus Life, Inc. updates its registration statement for a proposed offering of 10,000,000 shares of common stock, aiming to use the proceeds for operations, business strategy, and debt refinancing.

Summary

• Abacus Life, Inc. has filed an amendment to its Form S-1 registration statement with the SEC regarding a proposed offering of 10,000,000 shares of its common stock.
• The company intends to use the net proceeds from this offering for general operations, including the purchase of life settlement policies, supporting its overall business strategy, working capital, and potentially repaying or refinancing debt.
• The common stock is listed on The Nasdaq Capital Market under the symbol ABL, with the last reported sale price on June 12, 2024, at $10.41 per share.
• The underwriters have an option to purchase up to an additional 1,500,000 shares of common stock within 30 days from the date of the prospectus.
• The document includes summaries of historical financial data for Abacus Life, Inc. and Abacus Settlements, highlighting revenues, costs, and profitability metrics for various periods.
• Risk factors associated with the business and ownership of the stock are detailed, including valuation uncertainties, forecasting life expectancies, competition, regulatory risks, and cybersecurity threats.
• The company's mission is to educate life insurance policy owners about their policies as personal property and to educate investors about lifespan-based investment products.
• Abacus operates through ABL Tech, ABL Wealth and ABL Longevity Growth and Income Funds.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While it highlights the company's mission, market position, and growth potential, it also acknowledges significant risks and challenges, including valuation uncertainties, competition, and regulatory hurdles. The financial results show a decrease in net income and adjusted EBITDA for the three months ended March 31, 2024, compared to the same period in the previous year, which tempers the positive aspects.

Positives

• Abacus Life has a proven track record of growth and strong asset returns.
• The company has a seasoned management team with extensive experience in the life settlement industry.
• Abacus Life has a multifaceted and dynamic revenue model.
• The company has a strong market position and efficient origination platform.
• Abacus Life is a Better Business Bureau Accredited Business with an A+ rating.

Negatives

• The company's valuation of life insurance policies is uncertain.
• Abacus Life could fail to accurately forecast life expectancies.
• The company may experience increased competition.
• Abacus Life's revenue is concentrated in a limited number of customers, some of which are related parties.
• There has been a negative public perception of the life settlement industry.
• The company may become subject to claims by life insurance companies, individuals and their families, or regulatory authorities.
• The company faces privacy and cybersecurity risks.

Risks

• The company's valuation of life insurance policies is uncertain.
• Abacus Life could fail to accurately forecast life expectancies.
• The company's policy acquisitions are limited by market availability.
• Abacus Life may experience increased competition.
• The company's revenue is concentrated in a limited number of customers.
• There is a risk of fraud in the origination of life insurance policies.
• The company may become subject to claims by life insurance companies, individuals and their families or regulatory authorities.
• The company faces privacy and cybersecurity risks.
• The company is subject to U.S. privacy laws and regulations.
• The originating life insurance company may increase the cost of insurance premiums.
• The company may not be able to liquidate its life insurance policies.
• The company assumes the credit risk associated with life insurance companies.
• The company's success is dependent upon the services of its experienced management and talented employees.
• The company's intellectual property rights may not adequately protect the company's business.
• The company may become subject to intellectual property disputes.
• The company's ability to adapt and respond effectively to rapidly changing technology may have a material adverse impact on its competitiveness.
• Pandemics, along with rising interest rates and inflation, may disrupt the ability of the company and its providers to originate life settlement policies which could have a material adverse impact on the company's financial position.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company's management has limited experience in operating a public company.
• The company's indebtedness may restrict its operations.
• The company may incur substantially more debt, which could exacerbate further the risks associated with its leverage.

Future Outlook

The company intends to use the net proceeds for operations, including the purchase of life settlement policies, supporting its overall business strategy, working capital purposes and general corporate purposes, which may include repayment and refinancing of our indebtedness.

Management Comments

• The Companys mission is to educate all life insurance policy owners that their life insurance policy is personal property and to educate investors about alternatives to traditional investments using lifespan-based products as a core strategy.

Industry Context

Abacus Life operates in the life settlements industry, which involves the purchase and sale of existing life insurance policies. The industry is growing but remains underpenetrated, presenting a significant opportunity for companies like Abacus to increase market share by raising awareness and educating consumers about the option to monetize their life insurance policies.

Comparison to Industry Standards

• Abacus Life claims approximately 20% market share based on 2022 data, indicating a leading position compared to other players in the life settlements industry.
• The document mentions that life settlements companies pay sellers nearly eight times more than the current cash value of a policy, which is a standard benchmark in the industry.
• The document references The Deal and Life Settlements Report, a U.S. life settlements industry news source, suggesting that the company benchmarks its performance against industry reports and data.

Related Party Transactions

• The company has a related-party relationship with Nova Trading (US), LLC and Nova Holding (US) LP, as the owners of Abacus jointly own 11% of the Nova Funds.
• The SPV Purchase and Sale Note of $27,341,832 is a related party transaction given the transfer of cash and policies between the Company and the SPV, which is jointly owned by the Sponsor and former members of LMA and Abacus.
• The Sponsor PIK Note for $11,452,687 is also recorded as a related party transaction given the relationship between the Sponsor and the Company.

Stakeholder Impact

• Shareholders will experience dilution as a result of the new share issuance.
• The company's employees may benefit from the increased financial stability and growth potential resulting from the offering.
• Customers may benefit from the company's ability to invest in improving its services and expanding its reach.
• Creditors may benefit from the company's use of proceeds to repay or refinance debt.

Next Steps

• The company will proceed with the offering of common stock, subject to market conditions and regulatory approvals.
• The underwriters will market the shares to potential investors.
• The company will use the net proceeds from the offering for its operations, business strategy, working capital, and debt repayment.

Key Dates

Keywords

life settlements, insurance policies, common stock, origination, alternative asset manager, ABL Tech, ABL Wealth, ABL Longevity Growth and Income Funds, longevity, actuarial technology, investments, financial advisors, portfolio management, risk factors, prospectus